Basal Insulin: Innovative Approaches

Basal Insulin as a Foundation of Diabetes Treatments: Innovative Approaches

CME Information

1

Program Overview

This two-session activity, as part of the Joslin Diabetes Center Virtual Symposia Series, is designed to address current, topical challenges in the care of people who have diabetes and related conditions and comorbidities, updating providers on new treatment advances and guiding optimal strategies for personalized management of these conditions.

Accreditation/Designation Statements

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Primary Care Network and PlatformQ Health Education, LLC. Primary Care Network is accredited by the ACCME to provide continuing medical education for physicians.

Live Online Activity

Primary Care Network designates each live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Session I: Optimizing Basal Insulin Therapy: Evolving Tools and Treatment Designs
Wednesday, February 1, 2017 from 11:00AM – 12:00PM EST.

Session II: Optimizing Basal Insulin Therapy: Implementation, Management, and Overcoming Barriers
Wednesday, April 5, 2017 from 11:00AM – 12:00PM EST.

Online On-Demand Enduring Material

Primary Care Network designates each enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Enduring Materials Date of Release/Expiration

Session I: The enduring material will be available from February 1, 2017 – October 5, 2017.
Session II: The enduring material will be available from April 5, 2017 – October 5, 2017.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Describe the pharmacokinetics and pharmacodynamics of the newer ultra-long basal and follow-on biologic (“biosimilar”) insulin formulations and how these differ from older formulations
  • Determine indications and methods to transition from analog basal insulin to ultra-long basal insulins and follow-on biologic (“biosimilar”) basal insulins to help achieve individualized patient treatment goals
  • Examine the evidence-based, guideline-driven protocols for therapeutic advancement to basal insulin therapy alone or in combination with other treatment modalities to achieve individualized patient goals
  • Identify potential patient, provider, and health care system barriers to initiation and titration of established and newer basal insulins, and methods to overcome these barriers

Jointly provided by Primary Care Network, PlatformQ Health Education, LLC and its collaborating partner Joslin Diabetes Center.

PCN_web joslin_diabetes_center_logo

 

click-here
Participant will need to initially complete a short registration form with Diabetes Series Live to participate in this activity. Future participation in Diabetes Series Live activities will allow you to skip the registration process and only require you to log-in.

Published February 12, 2017

 


0 Comment

Would you like to join the discussion? Feel free to contribute!

Write a Reply or Comment

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Recent Advances in In… January 4, 2017 ‘Tis the Season: Re… January 9, 2017